Transactions

$115 Million
Co-Lead Placement Agent
Private Placement
April 2022

UNDISCLOSED
Financial Advisor
Merger with MoonLake Immunotherapeutics
April 2022

$25 Million
Joint Bookrunner
Follow-On
March 2022

$10 Million
Joint Bookrunner
Follow-On
March 2022

$6.0 Billion
Financial Advisor
Sale to Optum Health, a UnitedHealth Group Company
Pending

$69 Million
Joint Bookrunner
Initial Public Offering
March 2022

UNDISCLOSED
Capital Markets and Financial Advisor
Merger with Avista Public Acquisition Corp. II
Pending

$700 Million
Joint Bookrunner
Follow-On
March 2022

UNDISCLOSED
Lead Financial Advisor
Sale to Clearlake Capital Group
Pending

$275 Million
Joint Bookrunner
Convertible Senior Note Offering
March 2022

$1.9 Billion
Financial Advisor
Sale to UCB
March 2022

$75 Million
Joint Bookrunner
Follow-On
March 2022